Company: AOSL
Filing Date: 2025-08-28
Form Type: 10-K
Source: 0001628280-25-041297
Chunk: 137

Company: ALPHA & OMEGA SEMICONDUCTOR Ltd
Filing Date: 2025-08-28
Form: 10-K
Item: Item 7
Chunk 137
---
76.8 million other-than-temporary impairment of the equity method investment was recognized as of June 30, 2025.  The impairment loss is recorded within equity method investment loss in the consolidated statement of operations for the fiscal year ended June 30, 2025.

Results of Operations

 A discussion of our results of operations for the fiscal year ended June 30, 2025 to June 30, 2024 is included below.  For a discussion and comparison of the results of our operations for the fiscal year ended June 30, 2024 with the fiscal year ended June 30, 2023, refer to “Management’s Discussion and Analysis of Financial Conditions and Results of Operations” in our Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC on August 23, 2024.

46

Operating results

The following tables set forth our results of operations and as a percentage of revenue for the fiscal years ended June 30, 2025 and 2024.  Our historical results of operations are not necessarily indicative of the results for any future period.

 Year Ended June 30,  2025202420252024(in thousands)(% of revenue)Revenue$696,162 $657,274 100.0 %100.0 %Cost of goods sold (1)535,158 485,356 76.9 %73.8 %Gross profit161,004 171,918 23.1 %26.2 %Operating expenses:Research and development (1)94,265 89,940 13.5 %13.7 %Selling, general and administrative (1)95,175 85,734 13.7 %13.0 %Total operating expenses189,440 175,674 27.2 %26.7 %Operating loss(28,436)(3,756)(4.1)%(0.5)%Other loss, net(1,004)(73)(0.1)%— %Interest income 4,283 5,168 0.6 %0.8 %Interest expenses(2,639)(3,982)(0.4)%(0.6)%Net loss before income taxes and equity method investment loss(27,796)(2,643)(4.0)%(0.3)%Income tax expense (benefit)(8,625)3